Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.
about
Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotypeMyeloid-derived suppressor cells: linking inflammation and cancerInhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 proteinTumor-specific Th17-polarized cells eradicate large established melanomaCancer immunoediting from immune surveillance to immune escapeTargeting microRNAs as key modulators of tumor immune responseMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaRegulation of Natural Killer Cell Function by STAT3Cancer stem cells and immunoresistance: clinical implications and solutionsThe Role of the Transcriptional Regulation of Stromal Cells in Chronic InflammationSignaling Circuits and Regulation of Immune Suppression by Ovarian Tumor-Associated MacrophagesTargeting the tumor microenvironment: JAK-STAT3 signalingThe role of obesity in gastrointestinal cancer: evidence and opinionCancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer controlMyeloid-derived suppressor cells and anti-tumor T cells: a complex relationshipMechanisms driving macrophage diversity and specialization in distinct tumor microenvironments and parallelisms with other tissuesTargeting the innate immune system as immunotherapy for acute myeloid leukemiaMembrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cellsImmunity, Inflammation, and CancerAptamers: A New Technological Platform in Cancer ImmunotherapyPhenotype, development, and biological function of myeloid-derived suppressor cellsSignal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapyMyeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacyMyeloid-derived suppressor cells as regulators of the immune systemDangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancerStat3 mediates myeloid cell-dependent tumor angiogenesis in miceInflammation and skeletal metastasisChemical probes that competitively and selectively inhibit Stat3 activationThe anthelmintic drug niclosamide induces apoptosis, impairs metastasis and reduces immunosuppressive cells in breast cancer modelBovine lactoferrin counteracts Toll-like receptor mediated activation signals in antigen presenting cellsSTATs in cancer inflammation and immunity: a leading role for STAT3STAT3 regulates uterine epithelial remodeling and epithelial-stromal crosstalk during implantationMyeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species.Tumor masses support naive T cell infiltration, activation, and differentiation into effectorsM-HIFU inhibits tumor growth, suppresses STAT3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancerS1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.A network-based method for mechanistic investigation of Shexiang Baoxin Pill's treatment of cardiovascular diseases.Celecoxib induces apoptosis and cell-cycle arrest in nasopharyngeal carcinoma cell lines via inhibition of STAT3 phosphorylation.Networks inferred from biochemical data reveal profound differences in toll-like receptor and inflammatory signaling between normal and transformed hepatocytes.
P2860
Q24312920-08621083-2674-4450-8FD5-F9847170FE56Q24631473-12DA3EBC-9EB1-4835-8F58-BC29ACDFB790Q24641811-BDE7293E-141B-4AAB-936F-96FC81EBD616Q24641894-C132F205-E590-4F5E-BAFC-C9070E724E9CQ24648032-6EA2771B-2547-4CC4-A693-AB0EC0A0221CQ24655415-972B79E8-CAB3-4D02-BF51-EB557EBC0C6DQ26746972-E1A1F49B-56B3-485E-8627-FCA146C05FAFQ26747339-DF121932-288A-4B5B-BA47-B1D06BC04BC7Q26752551-624FC7A5-EB63-4170-A354-4645A913C3A9Q26769757-C6D9032D-56E0-4D52-B979-0DCCBB98FABCQ26778930-53E13771-0D32-4101-BF23-FCE65A78A6CCQ26783748-843819B0-4832-4362-A1E8-BBB765F55E0BQ26825658-4E6E092F-98F5-4C73-BBBB-0E3DA48E61EAQ26825678-05E46521-A3DE-42A9-A26B-E06098153041Q26860058-DD762EC2-959B-4990-9387-8271C7A725F9Q27000087-FDFCE117-5F6B-4DBC-9616-638FD8C7A858Q27003907-E34D0709-CF7A-4962-85CB-7039B32FF1BCQ27015876-22659A2B-AE09-48D6-AAB1-EF566EA2A1D1Q27309991-0A0D9BCF-00CE-4DEE-B599-B628205F4560Q27861048-75B05CF1-171E-4040-BBC4-DC5D1DBB1F88Q28068981-8E8D4978-4C8D-4306-9168-BE2F368F1C50Q28079046-FA8BADB1-EC97-40F9-9F18-AEDE164A017DQ28080262-A5D0E637-B2B3-44FE-A49E-6779D4C7B7A4Q28082461-06A3F316-AD24-4695-8ED0-71304848B913Q28131637-54B7FF06-6843-4A59-B2B6-C230CAA23A29Q28267996-A85A7CFD-6C31-4A1B-879F-7C0F33778012Q28385532-704DC380-4F86-4116-BE1A-80B63196EE95Q28396089-5202BD2C-3FCF-4243-9DE4-D94024655C8CQ28475010-13F1E0B7-4ABA-4391-AADC-A565E06AA3C4Q28538542-F7D22D67-09FD-4EB3-BE9F-0D84CADE6FE3Q28742177-41F7FBE0-4B80-498A-B2FE-5EE35219B2C6Q29547203-7CDB194E-6DFB-4BF1-B38D-438DAE00EF45Q30409357-75F15F1F-8BD7-4A85-AF7C-BDE1811941DBQ30422587-5D2CEA8E-4420-48D5-B09F-E22336A7BCB7Q30433292-A6C30194-5173-4C08-8852-DDE6FFDDE3DAQ30465410-3A52358E-3FA5-4D0A-9E80-17C38680D98EQ30514214-2DC1C69C-009C-4C8A-B732-0D219D8520B5Q30841144-52D17729-370E-49CB-9AC1-C69D4188E9B5Q33567401-F05CC243-8772-45B5-9F2C-86A16F3E788DQ33575787-E1E9B61D-1E51-4477-AF79-AE149335F382
P2860
Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Inhibiting Stat3 signaling in ...... icomponent antitumor immunity.
@en
type
label
Inhibiting Stat3 signaling in ...... icomponent antitumor immunity.
@en
prefLabel
Inhibiting Stat3 signaling in ...... icomponent antitumor immunity.
@en
P2093
P2860
P356
P1433
P1476
Inhibiting Stat3 signaling in ...... icomponent antitumor immunity.
@en
P2093
Drew Pardoll
Guilian Niu
James Mulé
Maciej Kujawski
Marcin Kortylewski
Richard Jove
Shari Pilon-Thomas
P2860
P2888
P304
P356
10.1038/NM1325
P407
P577
2005-11-20T00:00:00Z